In order to further improve the policy of employees’ social medical insurance and reduce the burden of medical expenses on the employees’ social medical insurance participants, the management department has adjusted the scope and standard of outpatient designated chronic disease specialist drug fees paid by the employees’ social medical insurance co-ordination fund in accordance with the relevant provisions of the Guangzhou Social Medical Insurance Regulations and the Guangzhou Social Medical Insurance Measures. Excerpts of the documents related to rheumatology are as follows: 1. The chronic diseases of outpatient designated rheumatology that are included in the scope of outpatient specialist drug fees paid by the Employees’ Social Medical Insurance Coordinated Fund are: rheumatoid arthritis, chronic renal insufficiency (non-dialysis), ankylosing spondylitis, osteoarthritis of the knee joint and systemic lupus erythematosus. Second, the insured persons (hereinafter referred to as insured patients) who meet the “Guangzhou Social Medical Insurance Outpatient Designated Chronic Diseases Admission Criteria” (see annex) must be confirmed by the designated designated medical institutions and audited and confirmed. When the insured person applies for the designated outpatient chronic disease, the designated medical institution will review and confirm according to the corresponding outpatient designated chronic disease admission criteria. For those who have been diagnosed in the past, the designated medical institution can review and confirm them according to the past lab reports and diagnostic letters. (3) The insured patients who have been confirmed by the designated designated medical institutions to visit the designated medical institutions for outpatient treatment shall enjoy the medical insurance treatment for outpatient designated chronic diseases in accordance with the following provisions: (1) The outpatient designated chronic diseases corresponding to the outpatient drug costs incurred by the insured patients in the designated medical institutions in the city, or in the selected medical institutions in other places in accordance with the regulations, shall be paid by the employees’ social medical insurance fund at the rate of 85%, other medical institutions 65% of the standard payment. (2) The maximum payment limit of the social medical insurance fund for outpatient designated chronic diseases and general medical expenses is 200 yuan per month per patient. The maximum monthly payment limit of the Employees’ Social Health Insurance Fund is valid for the month and will not be rolled over or accumulated. (c) Patients with multiple outpatient designated chronic diseases can choose up to three of them to enjoy the corresponding outpatient designated chronic disease medical insurance treatment. Once the disease type is selected, it will not be changed within one year in principle. The insured patients are not allowed to enjoy medical insurance treatment for outpatient designated chronic diseases during hospitalization. (d) The social health insurance fund of the employees shall pay for the outpatient designated chronic diseases in accordance with the medical catalog of the city’s social health insurance outpatient designated chronic diseases. The specific outpatient designated chronic disease drug catalog is published on the portal of the Municipal Human Resources and Social Security Bureau (website: http: //www.hrssgz.gov.cn). 4. The outpatient designated chronic disease drugs and general treatment fees incurred by the insured patients are paid by the social health insurance fund and are first recorded by the social insurance designated medical institutions and then reported to the medical insurance agency for settlement after monthly summary. The outpatient designated chronic disease medicine and general treatment fees incurred by the insured patients in designated off-site medical institutions shall be reimbursed sporadically by the medical insurance agency in accordance with the regulations. If the designated medical institution does not meet the admission criteria, the medical institution will review and confirm the application for outpatient designated chronic diseases, and the corresponding outpatient designated chronic diseases and general medical fees incurred by the designated medical institution will be borne by the designated medical institution for review and confirmation. V. For outpatient designated chronic diseases that need to be diagnosed or treated by tertiary designated medical institutions, in Huadu District, Panyu District, Conghua District and Zengcheng District, the municipal medical insurance agency may select some of the diagnosis and treatment medical institutions among the local secondary designated medical institutions according to the scope of services and the actual level of diagnosis and treatment technology stipulated in the Approved Table of Medical Institutions by the health department. Sixth, this notice shall be implemented from January 1, 2016.